In separate statements, Santhera Pharmaceuticals of Switzerland and Newron Pharmaceuticals SpA of Italy have announced that discussions are taking place between them, the outcome of which cannot be predicted. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
